Showing 21-25 of 38 data studies & next generation registries:
OM1 Artificial Intelligence (AI) Shared Decision Aid Demonstrates Significant Improvement In Decision Quality And Surgical Outcomes For Knee Osteoarthritis

BOSTON, Feb. 18, 2021 /PRNewswire/ — OM1, a leading real-world data (RWD), health outcomes and technology company, today announced the publication of clinical trial results in JAMA Network Open demonstrating its tool, OM1™ Joint Insights, positively impacts decision quality, shared decision making, patient experience, and functional outcomes in adults with knee osteoarthritis (OA). In the U.S., more than 30 million adults[…]

Pearls and Pitfalls in Analyzing RWD for Autoimmune Diseases

Thu. Sep 10, 2020 2:00 PM – 3:00 PM EDT Register Real-world data (RWD) is playing an increasing role in health care decisions, especially with autoimmune diseases where diagnosis can be difficult and there is no cure. Despite the promises of RWD to improve our understanding of the natural history of these diseases and to[…]

A Magnet for the Haystack: Using AI to Find Rare Disease Patients

August 11, 2020 – HealthEconomics.com “Correctly identifying a patient with a rare disease can be like looking for a needle in a haystack”, according to Dr. Joseph Zabinski, Director, AI & Precision Medicine at OM1. But what if we could apply a magnet to the haystack, taking advantage of ‘hidden’ properties that – even without[…]

AAO-HNSF Partners With OM1 To Empower More Measured & Precise Care And Treatments For ENT

Collaboration enables otolaryngologists and researchers to leverage data for real-world evidence, outcomes, and personalized medicine programs BOSTON, May 13, 2020 — OM1, a real-world outcomes and technology company, today announced a strategic partnership with the American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF) connecting the Foundation’s Reg-entSM  clinical data registry to OM1’s real-world data[…]

RWD for Research & Regulatory: Collecting, Processing and Leveraging High-Quality Data

Tuesday, March 31 – 1:00 – 2:00 pm ET Register The promise of real-world data is driving increased requirements and use. But, what does high-quality RWD actually look like? How should life sciences companies access and use it most effectively? What are the implications when applying RWD to clinical trials, registries, and other evidence and[…]

1 … 3 4 5 6 7 8